{
    "nctId": "NCT04986306",
    "briefTitle": "The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer Patients",
    "officialTitle": "The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer Patients in National Cheng Kung University Hospital (NCKUH)",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Sentinel Lymph Node Biopsy, Neoadjuvant Therapy",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "The impact of clipped lymph node in patients who received SLNB and ALND following neoadjuvant chemotherapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u2265 20 years.\n* Female\n* Primary breast cancer, not metastasis from other cancer.\n* Histological subtypes: invasive ductal carcinoma.\n* Clinical stage: cT1-3, cN1, cM0.\n* Clip localization over at least one axillary lymph node.\n* After neoadjuvant chemotherapy (NCT). The inclusion criteria and regimens of NCT are followed standard guildline of National Cheng Kung University Hospital.\n* Complete response or partial response after NCT.\n* Written inform consent.\n\nExclusion Criteria:\n\n* Refuse to join the study.\n* Unable to complete standard regimens of NCT.\n* Metastasis in internal mammary nodes or other distant lymph nodes.\n* Pregnancy",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}